A study to evaluate the co-relation of expression levels of vascular endothelial growth factor C (VEGF-C) and SLUG to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) resistance in lung cancer patients
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics
- 01 Jun 2016 New trial record